Status:
WITHDRAWN
Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers
Lead Sponsor:
Antalya IVF
Conditions:
Pregnancy
Eligibility:
All Genders
20-42 years
Phase:
NA
Brief Summary
Currently all patients that have freeze-all ICSI treatment cycles have the start of their FET cycle scheduled with the use of OCP. While an excellent pregnancy rate (75%) for the patients that have a ...
Detailed Description
The patients will undergo standard assisted conception procedures; controlled ovarian stimulation (COS), oocyte pickup procedure (OPU), ICSI, embryo culture, blastocyst vitrification and frozen embryo...
Eligibility Criteria
Inclusion
- If patients have \>2 blastocysts vitrified
Exclusion
- All patients not willing to participate in the study
- Patients with any known adverse reaction to one or the other of the drugs prescribed
- All patients that have no surviving blastocysts for transfer
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02238431
Start Date
December 1 2014
End Date
June 1 2016
Last Update
May 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antalya IVF
Antalya, Antalya, Turkey (Türkiye), 07080